Interleukin-10 is a growth factor for human melanoma cells and down-regulates HLA class-I, HLA class-II and ICAM-1 molecules

International Journal of Cancer

Volumn 71, Issue 4, 1997, Pages 630-637

  Yue, Feng Yun ^a   Dummer, Reinhard ^a   Geertsen, Ralf ^a   Hofbauer, Günther ^a   Laine, Elisabeth ^a   Manolio, Silvana ^a   Burg, Günter ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH FACTOR; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 10 RECEPTOR;

ARTICLE; AUTOCRINE EFFECT; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MELANOMA CELL; PRIORITY JOURNAL;

ANTIBODIES, MONOCLONAL; ANTIGENS, NEOPLASM; DOWN-REGULATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, MHC CLASS I; GENES, MHC CLASS II; GROWTH SUBSTANCES; HLA ANTIGENS; HLA-D ANTIGENS; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-10; LYMPHATIC METASTASIS; MELANOMA; NEOPLASM METASTASIS; POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; SKIN NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0030950036     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19970516)71:4<630::AID-IJC20>3.0.CO;2-E     Document Type: Article

References (27)

1. 3H]thymidine incorporation assay. J. immunol Med., 170, 211-224 (1994).
2. BECKER, J.C., SCHWINN, A., DUMMER, R., BURG, G. and BROCKER, E.B., Lesion-specific activation of cloned human tumor-infiltrating lymphocytes by autoloeous tumor cells: induction of proliferation and cytokine production. J. invest. Dermatol., 101, 15-21 (1993).
3. BUTCH, A.W., CHUNG, G.H., HOFFMANN, J.W. and NAHM, M.H., Cytokine expression by germinal centre cells. J. Immunol., 150, 39-45 (1993).
4. CHEN, Q., DANIEL, V., MAHER, D. and HERSEY, P., Production of IL-10 by melanoma cells: examination of its role in immunosuppression mediated by melanoma. Int. J. Cancer. 56, 755-760 (1994).
5. DE WAAL MALERT, R., ABRAMS, J., BENNETT, B., FIGDOR, C. and DE VRIES, J.E., IL-10 inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J. exp. Med., 174, 1209-1220 (1991).
6. DE WIT, D., FLEMMING, C.L., HARRIS, J.D., PALMER, K.J., MOORE, J.S., GORE, M.E. and COLUNS, M.K., IL-12 stimulation but not B7 expression increases melanoma killine by patient cytotoxic T lymphocytes (CTL). Clin. exp. Immunol., 105, 353-359 (1996).
7. DLMMER, W., BASTIAN, B.C., ERNST. N., SCHÄNZLE, C., SCHWAAF, A. and BRÖCKER, E.B., Interleukin-10 production in malignant melanoma: preferential detection of IL-10-secreting tumor cells in metastatic lesions. Int. J. Cancer, 66, 607-610 (19960).
8. DUMMER, R., HEALD, P.W., NESTLE, F.O., LUDWIG, E., LAINE, E., HEMMI, S. and BURG, G., Sézary syndrome's T-cell clones display T helper 2 cytokines and express the accessory factor-1 (interteron e receptor β chain). Blood, 41, 1-17 (1996b).
9. DUMMER, R., KOHL, O., GILLISSION, J., KÄGI, M. and BURG, G., Peripheral blood mononuclear cells in non-leukemic cutaneous T-cell lymphoma patients: reduced proliferation and preferential secretion of a T-helper-2-like cytokine pattern on stimulation. Arch. Dermatol., 129, 433-437 (1993).
10. ENK, A.H. and KATZ, S.I., Identification and induction of keratinocyte-derived IL-10. J. Immunol., 149, 92-95 (1992).
11. FIORENTINO, D.F., BOND, M.W. and MOSMANN, T.R., Two types of mouse T-helper cells. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J. exp. Med., 170, 2081-2095 (1989).
12. FIORENTINO, D.F., ZLOTNIK, A., VIEIRA, P., MOSMANN, T.R., HOWARD, W., MOORE, K.W. and O'GARRA. A., IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J. Immunol., 146, 3444-3451 (1991).
13. GASTL, G.A., ABRAMS, J.S., NANUS, D.M., OOSTERKAMP, R., SILVER, J., LIU, F. CHEN, M., ALBINO, A.P. and BANDER. N.H., Interleukin-10 production by human carcinoma cell lines and its relationship to interleukin-6 expression. Int. J. Cancer. 55, 96-101 (1993).
14. GOTLIEB, W.H., ABRAMS, J.S., WATSON, J.M., VELU, T.J., BEREK, J.S. and MARTINEZ-MAZA, O., Presence of interleukin 10 (IL-10) in the ascites of patients with ovarian and other intra-abdaminal cancers. Cytokine, 4, 385-390 (1992).
15. KALTOFT, K., Cytogenetic findings in cell lines from cutaneous T-cell lymphoma. Dermatol. Clin., 12, 2 (1994).
16. KRÜGER-KRASAGAKES, S., KRASAGAKIS, K., GARBE, C. SCHMITT, E., HULS, C., BLANKENSTEIN, T. and DIAMANTASTEIN, T., Expression of interleukin-10 in human melanoma. Brit. J. Cancer. 70, 1182-1185 (1994).
17. LANTIME, E., MASTRANGELO, M., BAGASRA, O., LI, W. and BERD, D., Expression of cytokine mRNA in human melanoma tissues. Cancer Immunol. Immunother., 41, 151-156 (1995).
18. MATSUDA, M., SALATAR, F., PETERSSON, M., MASUCCI, G., HANSSON, J., PISA, P., ZHANG, Q.J., MASUCCI, M.G. and KIESSLING, R., Interleukin-10 pretreatment protects target cells from tumor- and allo-specific cytotoxic T cells and downregulates HLA class-I expression. J. exp. Med., 180, 2371-2376 (1994).
19. MORM, M., REICHERT, U., DIPPEL, E., CZARNETZKI, B.M. and SCHADENDORF, D., Expression of growth factor receptors on human melanoma cells: comparison of modulation effects of interferons and retinoids. Exp. Dermatol., 2, 217-223 (1993).
20. O'GARRA, A. and 13 OTHERS, Production of cytokines by mouse B cells: B lymphomas and normal B cells produce IL-10. Int. Immunol., 2, 821-827 (1990).
21. PISA, P., HALAPI, E., PISA, E.K., GERDIN, E., HISING, C., BUCHT, A., GERDIN, B. and KIESSLING, R., Selective expression of interleukin 10, interferon-g and granulocyte-macrophage colony-stimulating factor in ovarian cancer biosies. Proc. nat. Acad. Sci. (Wash.). 89, 7708-7712 (1992).
22. REILLY, P.L., WOSKA, J.R., JEANFAVRE, J.D.D., MCNALLY, E., ROTHLEIN, R. and BORMANN, B.J., The native structure of intercellular adhesion molecule-1 (ICAM-1) is a dimer. Correlation with binding to LFA-1. J. Immunol., 155, 529-532 (1995).
23. ROBBINS, P.A., EVANS, E.L., DING, A.H., WARNER, N.L. and BRODSKY, F.M., Monoclonal antibodies that distinguish between class II antigens (HLA-DP, DQ, and DR) in 14 haplotypes. Hum. Immunol., 18, 301-313 (1987).
24. SHIH, I.M. and HERLYN, M., Role of growth factors and their receptors in the development and progression of melanoma. J. invest, Dermatol., 100, 196-203 (1993).
25. SLOMINSKI, A., ROSS, J. and MIHM, M.C., Cutaneous melanoma: pathology, relevant prognostic indicators and progression. Brit. Med. Bull., 51, 548-569 (1995).
26. TAGA, K. and TOSATO, G., IL-10 inhibits human T cell proliferation and IL-2 production. J Immunol., 148, 1143-1148 (1992).
27. VIEIRA, P., DE WAAL MALEFYT, R., DANG, M.-N., JOHNSON, K.E., KASTELEIN, R., FIORENTINO, D.E., DE VRIES, J.E., RONCAROLO, M.-G., MOSMAN, T.R. and MOORE, K.W., Isolation and expression of human cytokine synthesis inhibitory factor cDNA clones: homoloay to Epstein-Barr virus open reading frame BCRFI. Proc. nat. Acad. Sci. (Wash.), 88, 1172-1176 (1991).